Daphne Quimi Amicus Therapeutics, Inc. (FOLD) insider trading activity

Daphne Quimi is Chief Financial Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 398,532 shares of FOLD, which is worth approximately $3.97 Million. The most recent transaction as insider was on Jan 18, 2023, when has been sold 6,923 shares (Common Stock) at a price of $13.0 per share, resulting in proceeds of $89,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 399K

0% 3M change

0% 12M change

Total Value Held $3.97 Million

Daphne Quimi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 18 2023	SELL Open market or private sale	$89,999 $13.0 p/Share	6,923 Reduced 1.71%	398,532 Common Stock
Jan 17 2023	SELL Open market or private sale	$62,450 $12.49 p/Share	5,000 Reduced 1.22%	405,455 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$355,371 $12.02 p/Share	29,565 Reduced 6.72%	410,455 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	58,824 Added 11.79%	440,020 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$46,724 $12.03 p/Share	3,884 Reduced 1.01%	381,196 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$102,299 $11.93 p/Share	8,575 Reduced 2.18%	385,080 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	73,508 Added 15.73%	393,655 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$185,164 $12.21 p/Share	15,165 Reduced 4.52%	320,147 Common Stock
Sep 01 2022	SELL Open market or private sale	$49,642 $11.29 p/Share	4,397 Reduced 1.29%	335,312 Common Stock
Aug 05 2022	SELL Open market or private sale	$69,576 $12.0 p/Share	5,798 Reduced 1.68%	339,709 Common Stock
Jun 17 2022	SELL Open market or private sale	$39,564 $9.0 p/Share	4,396 Reduced 1.26%	345,507 Common Stock
Jan 14 2022	SELL Payment of exercise price or tax liability	$198,417 $10.53 p/Share	18,843 Reduced 5.11%	349,903 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	36,840 Added 9.08%	368,746 Common Stock
Jan 04 2022	SELL Payment of exercise price or tax liability	$50,432 $12.48 p/Share	4,041 Reduced 1.2%	331,906 Common Stock
Jan 03 2022	SELL Payment of exercise price or tax liability	$18,625 $12.11 p/Share	1,538 Reduced 0.58%	262,811 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	73,136 Added 17.88%	335,947 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$182,236 $11.55 p/Share	15,778 Reduced 5.63%	264,349 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$121,298 $11.55 p/Share	10,502 Reduced 3.61%	280,127 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	19,295 Added 6.23%	290,629 Common Stock
Mar 05 2021	SELL Payment of exercise price or tax liability	$48,879 $10.48 p/Share	4,664 Reduced 1.69%	271,334 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	$48,886 $2.94 p/Share	16,628 Added 5.68%	275,998 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$104,177 $21.84 p/Share	4,770 Reduced 1.81%	259,370 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	9,502 Added 3.47%	264,140 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	33,131 Added 11.51%	254,638 Common Stock
Jan 03 2021	SELL Payment of exercise price or tax liability	$116,674 $23.09 p/Share	5,053 Reduced 2.23%	221,507 Common Stock

Also insider at

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

IPSC

Century Therapeutics, Inc. Healthcare

Director

Daphne Quimi

Chief Financial Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account